There is clinical overlap between HLH and MAS, though the driving pathophysiologic process is thought to differ, but the discussion of the distinctions and the best classification to use for patients with XIAP deficiency is beyond the scope of this review. This evidence concerns the gene XIAP and hemophagocytic syndrome.